Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non‐disease‐specific pathway of functional neurologic improvement

INTRODUCTION: Intranasal deferoxamine (IN DFO) has been shown to decrease memory loss and have beneficial impacts across several models of neurologic disease and injury, including rodent models of Alzheimer's and Parkinson's disease. METHODS: In order to assess the mechanism of DFO, determ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain Behav
Hauptverfasser: Fine, Jared M., Kosyakovsky, Jacob, Baillargeon, Amanda M., Tokarev, Julian V., Cooner, Jacob M., Svitak, Aleta L., Faltesek, Katherine A., Frey, William H., Hanson, Leah R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066355/
https://ncbi.nlm.nih.gov/pubmed/31960628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1536
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge